These findings were consistent with previous reports showing that LINC00162 was overexpressed in breast cancer cell lines MDA‐MB‐231,16 as well as a study by Piipponen et al,17 who observed that LINC00162 promotes tumorigenesis in cutaneous squamous cell carcinoma, suggesting that LINC00162 has an oncogenic role in PDAC and may further act as a novel biomarker or therapeutic target. The gene discussed is PICSAR; the disease is breast carcinoma.